<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Genetic disorders of the collecting tubule sodium channel: Liddle syndrome and pseudohypoaldosteronism type 1</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Genetic disorders of the collecting tubule sodium channel: Liddle syndrome and pseudohypoaldosteronism type 1</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Genetic disorders of the collecting tubule sodium channel: Liddle syndrome and pseudohypoaldosteronism type 1</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">William F Young, Jr, MD, MSc</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Richard H Sterns, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">André Lacroix, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John P Forman, MD, MSc</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 03, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Liddle syndrome and autosomal recessive pseudohypoaldosteronism type 1 are rare genetic disorders associated with abnormalities in the function of the collecting tubule sodium channel, also called the epithelial sodium channel (ENaC) or the amiloride-sensitive sodium channel:</p><p class="bulletIndent1"><span class="glyph">●</span>ENaC function is increased in Liddle syndrome, leading to manifestations similar to those caused by mineralocorticoid excess, such as hypertension and, in some patients, hypokalemia and metabolic alkalosis. Presentation at a young age, which occurs in most patients, suggests the possibility of a genetic disorder rather than an adrenal adenoma. In addition, plasma and urinary aldosterone levels are reduced, not increased as in primary aldosteronism.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>ENaC function is decreased in autosomal recessive pseudohypoaldosteronism type 1, resulting in aldosterone resistance. Affected patients present in infancy with sodium wasting, hypovolemia, and hyperkalemia. These findings are similar to those in other forms of hypoaldosteronism in children, except that plasma aldosterone levels are elevated, not reduced.</p><p></p><p>The clinical presentation, genetics, and management of Liddle syndrome and pseudohypoaldosteronism will be reviewed here. Other causes of hypertension and hypokalemia, and of hypoaldosteronism are reviewed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/138.html" rel="external">"Diagnosis of primary aldosteronism"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/2306.html" rel="external">"Etiology, diagnosis, and treatment of hypoaldosteronism (type 4 RTA)"</a>.)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">COLLECTING TUBULE SODIUM CHANNEL</span><span class="headingEndMark"> — </span>The cortical collecting tubule contains two cell types with different functions: principal cells (approximately 65 percent) and intercalated cells:</p><p class="bulletIndent1"><span class="glyph">●</span>The principal cells have sodium and potassium channels in the luminal (apical) membrane and, as in all sodium reabsorbing cells, Na-K-ATPase pumps in the basolateral membrane (<a class="graphic graphic_figure graphicRef60693" href="/d/graphic/60693.html" rel="external">figure 1</a>) [<a href="#rid1">1-3</a>]. Aldosterone-sensitive sodium channels, also called epithelial sodium channels (ENaCs), are present in the colon and sweat glands as well as the collecting tubule.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The intercalated cells are primarily involved in hydrogen, bicarbonate, and potassium handling (<a class="graphic graphic_figure graphicRef51361" href="/d/graphic/51361.html" rel="external">figure 2</a>). They do not reabsorb sodium, since they have a lower level of Na-K-ATPase activity and few, if any, apical membrane sodium channels [<a href="#rid3">3,4</a>].</p><p></p><p>The principal cells contribute to net sodium reabsorption and are the primary site of potassium secretion. The entry of sodium into these cells primarily occurs down a concentration gradient through the luminal sodium channels (<a class="graphic graphic_figure graphicRef60693" href="/d/graphic/60693.html" rel="external">figure 1</a>) [<a href="#rid1">1-3</a>].</p><p>Aldosterone plays a central role in these processes, mainly by increasing the number of open luminal sodium channels [<a href="#rid5">5,6</a>]. As an example, going from a high- to a low-sodium diet (which is associated with enhanced aldosterone release and increased sodium reabsorption in the cortical collecting tubule) can increase the number of open sodium channels per cell from less than 100 to approximately 3000 [<a href="#rid2">2</a>]. There is also a later increase in Na-K-ATPase activity and open luminal potassium channels.</p><p>Although increased intracellular sodium concentrations downregulate the activity of the luminal sodium channels, increased export of cell sodium via increased Na-K-ATPase activity assures that increased numbers of sodium channels remain open [<a href="#rid7">7</a>].</p><p><a class="drug drug_general" data-topicid="8550" href="/d/drug information/8550.html" rel="external">Amiloride</a> blocks the collecting tubule sodium channels, leading to natriuresis and potassium retention [<a href="#rid1">1</a>]. Data derived from cloned sodium channel genes indicate that the site of amiloride binding is distinct from the channel pore [<a href="#rid1">1,8</a>]. Within the kidney, the sodium channel is primarily expressed in the late distal tubule and cortical and outer medullary portions of the collecting tubule [<a href="#rid9">9</a>].</p><p class="headingAnchor" id="H3"><span class="h1">LIDDLE SYNDROME</span></p><p class="headingAnchor" id="H4"><span class="h2">Clinical presentation</span><span class="headingEndMark"> — </span>Liddle syndrome is a rare autosomal dominant condition in which there is a primary increase in collecting tubule sodium reabsorption and, in most cases, potassium secretion [<a href="#rid10">10-13</a>]. Affected patients typically present with hypertension, hypokalemia, and metabolic alkalosis, findings that are similar to those seen in other disorders caused by mineralocorticoid excess [<a href="#rid14">14</a>]. Most patients present at a young age, but some are not detected until well into adulthood [<a href="#rid15">15</a>].</p><p>However, some patients with Liddle syndrome are not hypokalemic at presentation [<a href="#rid10">10,16</a>]. In one kindred, for example, the average serum potassium of 18 affected family members was 3.6 mEq/L [<a href="#rid10">10</a>]. In the absence of hypokalemia, the positive family history of early onset hypertension and, in some members, hypokalemia would be the major findings suggesting possible Liddle syndrome. Absence of hypokalemia has also been demonstrated in the majority of patients with primary aldosteronism. (See  <a class="medical medical_review" href="/d/html/140.html" rel="external">"Pathophysiology and clinical features of primary aldosteronism", section on 'Hypokalemia: An inconsistent finding'</a>.)</p><p class="headingAnchor" id="H5"><span class="h2">Pathogenesis</span><span class="headingEndMark"> — </span>Correction of the hypokalemia and hypertension in one patient with Liddle syndrome by kidney transplantation suggested that enhanced activity of the luminal membrane sodium channels, not increased secretion of a non-aldosterone mineralocorticoid, was the underlying defect [<a href="#rid10">10</a>].</p><p>This hypothesis was confirmed by the demonstration that the genetic abnormality in Liddle syndrome involves gain-of-function pathogenic variants in <em>SCNN1A</em>, <em>SCNN1B</em>, and <em>SCNN1G</em>, which encode the alpha, beta, and gamma subunits of the epithelial sodium channel (ENaC), respectively [<a href="#rid12">12,17-20</a>]. Deletions or substitutions in a short proline-rich segment of the intracytoplasmic C-terminus cause an inability of these subunits to bind with an intracellular ubiquitin protein ligase (Nedd4) that normally removes the luminal sodium channel from the cell surface [<a href="#rid21">21,22</a>]. Liddle syndrome is classified into three types: type 1 (beta subunit, OMIM #177200), type 2 (gamma subunit, OMIM #618114), and type 3 (alpha subunit, OMIM #618126). In one systematic review, 31 different causative pathogenic variants in 72 families from four continents were identified [<a href="#rid14">14</a>].</p><p>Failure to remove sodium channels results in an inability to reduce their number in response to low levels of aldosterone that result from the volume expansion-mediated suppression of renin secretion. These pathogenic variants result in a "gain-of-function" that mimics the effects of hyperaldosteronism [<a href="#rid16">16,17,19,23-26</a>].</p><p>Expression of these abnormal genes in the Xenopus oocyte is associated with a marked increase in sodium transport and loss of inhibition of channel activity by elevated intracellular sodium concentrations [<a href="#rid7">7,24,26,27</a>]. On the other hand, the ability to respond to aldosterone is maintained [<a href="#rid28">28</a>].</p><p class="headingAnchor" id="H6"><span class="h2">Diagnosis</span><span class="headingEndMark"> — </span>Patients with Liddle syndrome classically present with the triad of hypertension, hypokalemia, and metabolic alkalosis at a relatively young age. The consistent findings among such individuals are low plasma renin activity and, in contrast to primary aldosteronism, reductions in both the plasma aldosterone concentration and urinary excretion of aldosterone [<a href="#rid10">10</a>].</p><p>The differential diagnosis of this constellation of abnormalities includes some forms of congenital adrenal hyperplasia, familial cortisol resistance, the syndrome of apparent mineralocorticoid excess, licorice ingestion, Cushing's syndrome, and a DOC-producing adrenal tumor. (See appropriate topic reviews.)</p><p>A positive family history of hypertension at a young age with some members being hypokalemic should lead to the suspicion of a genetic disorder. However, sporadic cases of Liddle syndrome have been described [<a href="#rid29">29</a>]. As a result, the absence of a family history does not preclude the diagnosis.</p><p><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fgtr%2F&amp;token=wEsKVFvqlKzpT%2BqOtddW%2Fy3%2BLj0shalBW%2BL1ZyL4tryNPgji1PaJ6Kbd%2Fo1hE9A6&amp;TOPIC_ID=2371" target="_blank">Genetic testing</a> of the genes encoding the three subunits of ENaC, <em>SCNN1A</em>, <em>SCNN1B</em>, and <em>SCNN1G</em>, provides definitive confirmation of Liddle syndrome [<a href="#rid12">12,14,30</a>]. Nearly all pathogenic variants are nonsense, frameshift, or missense mutations that delete or alter the proline-rich PY motif of a subunit.</p><p class="headingAnchor" id="H7"><span class="h2">Therapy</span><span class="headingEndMark"> — </span>Therapy in Liddle syndrome consists of prescribing <a class="drug drug_general" data-topicid="8550" href="/d/drug information/8550.html" rel="external">amiloride</a> or <a class="drug drug_general" data-topicid="10016" href="/d/drug information/10016.html" rel="external">triamterene</a>, potassium-sparing diuretics that directly block the collecting tubule sodium channels and can correct both the hypertension and, if present, the hypokalemia [<a href="#rid23">23,26,31-34</a>]. The mineralocorticoid antagonist <a class="drug drug_general" data-topicid="9943" href="/d/drug information/9943.html" rel="external">spironolactone</a> is ineffective since the increase in sodium channel activity in Liddle syndrome is not mediated by aldosterone [<a href="#rid10">10,34,35</a>].</p><p class="headingAnchor" id="H8"><span class="h1">PSEUDOHYPOALDOSTERONISM TYPE 1</span><span class="headingEndMark"> — </span>Pseudohypoaldosteronism type 1 is a rare hereditary disorder characterized by generalized resistance to the actions of aldosterone. It typically presents in infancy with sodium wasting, hypovolemia, and hyperkalemia. These features are similar to other forms of hypoaldosteronism in children except that plasma aldosterone levels are markedly elevated. (See  <a class="medical medical_review" href="/d/html/2306.html" rel="external">"Etiology, diagnosis, and treatment of hypoaldosteronism (type 4 RTA)"</a>.)</p><p>Two different modes of inheritance of pseudohypoaldosteronism type 1 have been described with somewhat different clinical features [<a href="#rid36">36-39</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Autosomal recessive pseudohypoaldosteronism type 1 (MIM #264350), involving the epithelial sodium channel (ENaC), in which the defect is permanent and affects all aldosterone target organs (including the kidney, colon, and sweat glands).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Autosomal dominant or sporadic pseudohypoaldosteronism type 1 (MIM #177735), which is due to heterozygous pathogenic variants in the NR3C2 gene coding for the mineralocorticoid receptor, in which the defect is limited to the kidney. This renal variant has an estimated prevalence of 1 in 80,000 newborns [<a href="#rid39">39</a>], and is associated with milder salt wasting than autosomal recessive disease, and often improves with age. This disorder and pseudohypoaldosteronism type 2 (also called Gordon's syndrome), which also does not involve the sodium channel, are discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/2306.html" rel="external">"Etiology, diagnosis, and treatment of hypoaldosteronism (type 4 RTA)", section on 'Pseudohypoaldosteronism type 2 (Gordon's syndrome)'</a> and  <a class="medical medical_review" href="/d/html/2306.html" rel="external">"Etiology, diagnosis, and treatment of hypoaldosteronism (type 4 RTA)"</a>.)</p><p></p><p class="headingAnchor" id="H9"><span class="h2">Autosomal recessive disease</span><span class="headingEndMark"> — </span>The genetic defect in the autosomal recessive form of pseudohypoaldosteronism type 1 involves the alpha, beta, or gamma subunits (SCNN1A, SCNN1B, SCNN1G) of the sodium channel, resulting in resistance to the stimulatory effect of aldosterone [<a href="#rid38">38,40</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>The majority of reported pathogenic variants are in the alpha subunit, most commonly frameshift or premature stop codon defects. Studies in the Xenopus oocyte expression system suggest that, although these abnormalities frequently result in marked reductions in channel activity, even a mild defect can cause salt wasting, hyponatremia, hyperkalemia, acidosis, and volume depletion.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beta and gamma pathogenic variants, due to frameshift and premature stop codon defects, are less common. Given the paucity of data relating to these abnormalities, an accurate correlation between genotype and clinical phenotype has not been performed.</p><p></p><p>In addition to the typically severe fluid and electrolyte disturbances [<a href="#rid41">41</a>], sodium channel activity is also impaired in the lung, often leading to frequent lower respiratory tract infections and excess airway liquid [<a href="#rid38">38,42,43</a>]. This manifestation plus associated increases in sweat sodium and chloride concentrations results in a clinical picture that can mimic cystic fibrosis, including recurrent episodes of chest congestion, coughing, and wheezing [<a href="#rid43">43</a>]. Two features different from cystic fibrosis are a reduction in respiratory symptoms after age five years and the absence of an increase in lung infections due to Pseudomonas aeruginosa [<a href="#rid43">43</a>]. (See  <a class="medical medical_review" href="/d/html/6369.html" rel="external">"Cystic fibrosis: Clinical manifestations of pulmonary disease"</a>.)</p><p>"Knockout" mice lacking the alpha subunit of the ENaC die in the neonatal period because of defective lung liquid clearance, while mice without either the beta or gamma subunit die of hyperkalemia but not defective lungs [<a href="#rid38">38,44,45</a>]. These findings suggest that only the alpha subunit is required for an air-filled lung, while all three subunits are required for an adequate response to aldosterone.</p><p class="headingAnchor" id="H10"><span class="h2">Treatment</span><span class="headingEndMark"> — </span>Initial therapy of autosomal recessive pseudohypoaldosteronism type 1 consists of a high-salt diet, which prevents volume depletion and, by enhancing sodium delivery to the potassium secretory site in the collecting tubules, increases potassium excretion and lowers the plasma potassium concentration. High-dose <a class="drug drug_general" data-topicid="8455" href="/d/drug information/8455.html" rel="external">fludrocortisone</a> (1 to 2 mg/day [versus 0.05 to 0.1 mg/day in adrenal insufficiency]) or carbenoxolone can be added if a high-salt intake is ineffective or not well tolerated [<a href="#rid46">46</a>].</p><p>The efficacy of carbenoxolone in autosomal recessive pseudohypoaldosteronism type 1 is presumably related to its antagonism of cortisol metabolism, thereby allowing cortisol (which circulates in much higher concentrations than aldosterone) to activate mineralocorticoid receptors. Indirect proof for this mechanism, which is the same as that seen with the active ingredient in licorice, was shown by the response to the administration of <a class="drug drug_general" data-topicid="9334" href="/d/drug information/9334.html" rel="external">dexamethasone</a>, a potent glucocorticoid with minimal mineralocorticoid activity. Dexamethasone abolished the effect of carbenoxolone, presumably by diminishing endogenous cortisol secretion [<a href="#rid46">46</a>]. (See  <a class="medical medical_review" href="/d/html/2346.html" rel="external">"Apparent mineralocorticoid excess syndromes (including chronic licorice ingestion)"</a>.)</p><p class="headingAnchor" id="H3074681605"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/109733.html" rel="external">"Society guideline links: Fluid and electrolyte disorders in adults"</a>.)</p><p class="headingAnchor" id="H11"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Liddle syndrome and autosomal recessive pseudohypoaldosteronism type 1 are rare genetic disorders associated with abnormalities in the function of the collecting tubule sodium channel: increased function in Liddle syndrome; and decreased function and resistance to aldosterone in pseudohypoaldosteronism. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with Liddle syndrome typically present at a relatively young age with hypertension and, in most cases, hypokalemia and metabolic alkalosis. These findings are similar to those caused by primary aldosteronism, except that both the plasma aldosterone concentration and urinary excretion of aldosterone are reduced (see <a class="local">'Liddle syndrome'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A positive family history of hypertension at a young age with some members being hypokalemic should lead to the suspicion of a genetic disorder. The diagnosis of Liddle syndrome is established by genetic testing. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>We recommend treatment with <a class="drug drug_general" data-topicid="8550" href="/d/drug information/8550.html" rel="external">amiloride</a> or <a class="drug drug_general" data-topicid="10016" href="/d/drug information/10016.html" rel="external">triamterene</a> (<a class="grade" href="https://medilib.ir/uptodate/show/grade_2" rel="external">Grade 1B</a>). These potassium-sparing diuretics directly treat the primary defect in this disorder by blocking the collecting tubule sodium channels. The mineralocorticoid antagonist <a class="drug drug_general" data-topicid="9943" href="/d/drug information/9943.html" rel="external">spironolactone</a> is ineffective since the increase in sodium channel activity is not mediated by aldosterone. (See <a class="local">'Therapy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with autosomal recessive pseudohypoaldosteronism type 1 typically present in infancy with sodium wasting, hypovolemia, and hyperkalemia. These features are similar to other forms of hypoaldosteronism in children, except that both the plasma aldosterone concentration and urinary excretion of aldosterone are markedly increased. (See <a class="local">'Pseudohypoaldosteronism type 1'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Sodium channel activity is also impaired in the lung and sweat glands, often leading to frequent lower respiratory tract infections and increased sweat sodium and chloride concentrations that mimic those in cystic fibrosis (see <a class="local">'Autosomal recessive disease'</a> above). In patients with autosomal recessive pseudohypoaldosteronism type 1:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>We recommend treatment with a high-salt diet (<a class="grade" href="https://medilib.ir/uptodate/show/grade_3" rel="external">Grade 1C</a>), which prevents volume depletion and, by enhancing sodium delivery to the potassium secretory site in the collecting tubules, increases potassium excretion and lowers the plasma potassium concentration. (See <a class="local">'Treatment'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>If a high-salt diet is not sufficiently effective or not well tolerated, we recommend high-dose <a class="drug drug_general" data-topicid="8455" href="/d/drug information/8455.html" rel="external">fludrocortisone</a> (1 to 2 mg/day [versus 0.05 to 0.1 mg/day in adrenal insufficiency]) or carbenoxolone (<a class="grade" href="https://medilib.ir/uptodate/show/grade_3" rel="external">Grade 1C</a>). (See <a class="local">'Treatment'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Canessa CM, Schild L, Buell G, et al. Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits. Nature 1994; 367:463.</a></li><li><a class="nounderline abstract_t">Frindt G, Sackin H, Palmer LG. Whole-cell currents in rat cortical collecting tubule: low-Na diet increases amiloride-sensitive conductance. Am J Physiol 1990; 258:F562.</a></li><li><a class="nounderline abstract_t">Sauer M, Flemmer A, Thurau K, Beck FX. Sodium entry routes in principal and intercalated cells of the isolated perfused cortical collecting duct. Pflugers Arch 1990; 416:88.</a></li><li><a class="nounderline abstract_t">Katz AI. Distribution and function of classes of ATPases along the nephron. Kidney Int 1986; 29:21.</a></li><li><a class="nounderline abstract_t">Sansom S, Muto S, Giebisch G. Na-dependent effects of DOCA on cellular transport properties of CCDs from ADX rabbits. Am J Physiol 1987; 253:F753.</a></li><li><a class="nounderline abstract_t">Schafer JA, Hawk CT. Regulation of Na+ channels in the cortical collecting duct by AVP and mineralocorticoids. Kidney Int 1992; 41:255.</a></li><li><a class="nounderline abstract_t">Kellenberger S, Gautschi I, Rossier BC, Schild L. Mutations causing Liddle syndrome reduce sodium-dependent downregulation of the epithelial sodium channel in the Xenopus oocyte expression system. J Clin Invest 1998; 101:2741.</a></li><li><a class="nounderline abstract_t">Li XJ, Xu RH, Guggino WB, Snyder SH. Alternatively spliced forms of the alpha subunit of the epithelial sodium channel: distinct sites for amiloride binding and channel pore. Mol Pharmacol 1995; 47:1133.</a></li><li><a class="nounderline abstract_t">Duc C, Farman N, Canessa CM, et al. Cell-specific expression of epithelial sodium channel alpha, beta, and gamma subunits in aldosterone-responsive epithelia from the rat: localization by in situ hybridization and immunocytochemistry. J Cell Biol 1994; 127:1907.</a></li><li><a class="nounderline abstract_t">Botero-Velez M, Curtis JJ, Warnock DG. Brief report: Liddle's syndrome revisited--a disorder of sodium reabsorption in the distal tubule. N Engl J Med 1994; 330:178.</a></li><li><a class="nounderline abstract_t">Palmer BF, Alpern RJ. Liddle's syndrome. Am J Med 1998; 104:301.</a></li><li><a class="nounderline abstract_t">Cui Y, Tong A, Jiang J, et al. Liddle syndrome: clinical and genetic profiles. J Clin Hypertens (Greenwich) 2017; 19:524.</a></li><li><a class="nounderline abstract_t">Khandelwal P, Deinum J. Monogenic forms of low-renin hypertension: clinical and molecular insights. Pediatr Nephrol 2022; 37:1495.</a></li><li><a class="nounderline abstract_t">Tetti M, Monticone S, Burrello J, et al. Liddle Syndrome: Review of the Literature and Description of a New Case. Int J Mol Sci 2018; 19.</a></li><li><a class="nounderline abstract_t">Findling JW, Raff H, Hansson JH, Lifton RP. Liddle's syndrome: prospective genetic screening and suppressed aldosterone secretion in an extended kindred. J Clin Endocrinol Metab 1997; 82:1071.</a></li><li><a class="nounderline abstract_t">Rayner BL, Owen EP, King JA, et al. A new mutation, R563Q, of the beta subunit of the epithelial sodium channel associated with low-renin, low-aldosterone hypertension. J Hypertens 2003; 21:921.</a></li><li><a class="nounderline abstract_t">Snyder PM, Price MP, McDonald FJ, et al. Mechanism by which Liddle's syndrome mutations increase activity of a human epithelial Na+ channel. Cell 1995; 83:969.</a></li><li><a class="nounderline abstract_t">Hansson JH, Nelson-Williams C, Suzuki H, et al. Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome. Nat Genet 1995; 11:76.</a></li><li><a class="nounderline abstract_t">Devonald MA, Karet FE. Renal epithelial traffic jams and one-way streets. J Am Soc Nephrol 2004; 15:1370.</a></li><li><a class="nounderline abstract_t">Enslow BT, Stockand JD, Berman JM. Liddle's syndrome mechanisms, diagnosis and management. Integr Blood Press Control 2019; 12:13.</a></li><li><a class="nounderline abstract_t">Goulet CC, Volk KA, Adams CM, et al. Inhibition of the epithelial Na+ channel by interaction of Nedd4 with a PY motif deleted in Liddle's syndrome. J Biol Chem 1998; 273:30012.</a></li><li><a class="nounderline abstract_t">Abriel H, Loffing J, Rebhun JF, et al. Defective regulation of the epithelial Na+ channel by Nedd4 in Liddle's syndrome. J Clin Invest 1999; 103:667.</a></li><li><a class="nounderline abstract_t">Shimkets RA, Warnock DG, Bositis CM, et al. Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 1994; 79:407.</a></li><li><a class="nounderline abstract_t">Schild L, Canessa CM, Shimkets RA, et al. A mutation in the epithelial sodium channel causing Liddle disease increases channel activity in the Xenopus laevis oocyte expression system. Proc Natl Acad Sci U S A 1995; 92:5699.</a></li><li><a class="nounderline abstract_t">Hansson JH, Schild L, Lu Y, et al. A de novo missense mutation of the beta subunit of the epithelial sodium channel causes hypertension and Liddle syndrome, identifying a proline-rich segment critical for regulation of channel activity. Proc Natl Acad Sci U S A 1995; 92:11495.</a></li><li><a class="nounderline abstract_t">Furuhashi M, Kitamura K, Adachi M, et al. Liddle's syndrome caused by a novel mutation in the proline-rich PY motif of the epithelial sodium channel beta-subunit. J Clin Endocrinol Metab 2005; 90:340.</a></li><li><a class="nounderline abstract_t">Rossi E, Farnetti E, Debonneville A, et al. Liddle's syndrome caused by a novel missense mutation (P617L) of the epithelial sodium channel beta subunit. J Hypertens 2008; 26:921.</a></li><li><a class="nounderline abstract_t">Auberson M, Hoffmann-Pochon N, Vandewalle A, et al. Epithelial Na+ channel mutants causing Liddle's syndrome retain ability to respond to aldosterone and vasopressin. Am J Physiol Renal Physiol 2003; 285:F459.</a></li><li><a class="nounderline abstract_t">Yamashita Y, Koga M, Takeda Y, et al. Two sporadic cases of Liddle's syndrome caused by De novo ENaC mutations. Am J Kidney Dis 2001; 37:499.</a></li><li><a class="nounderline abstract_t">Achard JM, Hadchouel J, Faure S, Jeunemaitre X. Inherited sodium avid states. Adv Chronic Kidney Dis 2006; 13:118.</a></li><li><a class="nounderline abstract_t">Jeunemaitre X, Bassilana F, Persu A, et al. Genotype-phenotype analysis of a newly discovered family with Liddle's syndrome. J Hypertens 1997; 15:1091.</a></li><li><a class="nounderline abstract_t">Wang C, Chan TK, Yeung RT, et al. The effect of triamterene and sodium intake on renin, aldosterone, and erythrocyte sodium transport in Liddle's syndrome. J Clin Endocrinol Metab 1981; 52:1027.</a></li><li><a class="nounderline abstract_t">Ono F, Harada H, Komatsu K, et al. Two cases of pseudoaldosteronism (Liddle's syndrome) in siblings. Endocrinol Jpn 1975; 22:163.</a></li><li><a class="nounderline abstract_t">Mutoh S, Hirayama H, Ueda S, et al. Pseudohyperaldosteronism (Liddle's syndrome): a case report. J Urol 1986; 135:557.</a></li><li><a class="nounderline abstract_t">Sakamoto N, Uda M, Kojima S, et al. Hypertension, hypokalemia and hypoaldosteronism with suppressed renin: a clinical study of a patient with Liddle's syndrome. Endocrinol Jpn 1981; 28:357.</a></li><li><a class="nounderline abstract_t">Hanukoglu A. Type I pseudohypoaldosteronism includes two clinically and genetically distinct entities with either renal or multiple target organ defects. J Clin Endocrinol Metab 1991; 73:936.</a></li><li><a class="nounderline abstract_t">Kuhnle U, Nielsen MD, Tietze HU, et al. Pseudohypoaldosteronism in eight families: different forms of inheritance are evidence for various genetic defects. J Clin Endocrinol Metab 1990; 70:638.</a></li><li><a class="nounderline abstract_t">Bonny O, Rossier BC. Disturbances of Na/K balance: pseudohypoaldosteronism revisited. J Am Soc Nephrol 2002; 13:2399.</a></li><li><a class="nounderline abstract_t">Zennaro MC, Hubert EL, Fernandes-Rosa FL. Aldosterone resistance: structural and functional considerations and new perspectives. Mol Cell Endocrinol 2012; 350:206.</a></li><li><a class="nounderline abstract_t">Chang SS, Grunder S, Hanukoglu A, et al. Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nat Genet 1996; 12:248.</a></li><li><a class="nounderline abstract_t">Adachi M, Nagahara K, Ochi A, et al. Acid-Base Imbalance in Pseudohypoaldosteronism Type 1 in Comparison With Type IV Renal Tubular Acidosis. J Endocr Soc 2022; 6:bvac147.</a></li><li><a class="nounderline abstract_t">Hanukoglu A, Bistritzer T, Rakover Y, Mandelberg A. Pseudohypoaldosteronism with increased sweat and saliva electrolyte values and frequent lower respiratory tract infections mimicking cystic fibrosis. J Pediatr 1994; 125:752.</a></li><li><a class="nounderline abstract_t">Kerem E, Bistritzer T, Hanukoglu A, et al. Pulmonary epithelial sodium-channel dysfunction and excess airway liquid in pseudohypoaldosteronism. N Engl J Med 1999; 341:156.</a></li><li><a class="nounderline abstract_t">Hummler E, Barker P, Gatzy J, et al. Early death due to defective neonatal lung liquid clearance in alpha-ENaC-deficient mice. Nat Genet 1996; 12:325.</a></li><li><a class="nounderline abstract_t">McDonald FJ, Yang B, Hrstka RF, et al. Disruption of the beta subunit of the epithelial Na+ channel in mice: hyperkalemia and neonatal death associated with a pseudohypoaldosteronism phenotype. Proc Natl Acad Sci U S A 1999; 96:1727.</a></li><li><a class="nounderline abstract_t">Arai K, Tsigos C, Suzuki Y, et al. Physiological and molecular aspects of mineralocorticoid receptor action in pseudohypoaldosteronism: a responsiveness test and therapy. J Clin Endocrinol Metab 1994; 79:1019.</a></li></ol></div><div id="topicVersionRevision">Topic 2371 Version 18.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8107805" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2316665" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Whole-cell currents in rat cortical collecting tubule: low-Na diet increases amiloride-sensitive conductance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2162037" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Sodium entry routes in principal and intercalated cells of the isolated perfused cortical collecting duct.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2870215" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Distribution and function of classes of ATPases along the nephron.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3661724" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Na-dependent effects of DOCA on cellular transport properties of CCDs from ADX rabbits.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1313121" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Regulation of Na+ channels in the cortical collecting duct by AVP and mineralocorticoids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9637708" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Mutations causing Liddle syndrome reduce sodium-dependent downregulation of the epithelial sodium channel in the Xenopus oocyte expression system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7603452" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Alternatively spliced forms of the alpha subunit of the epithelial sodium channel: distinct sites for amiloride binding and channel pore.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7806569" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Cell-specific expression of epithelial sodium channel alpha, beta, and gamma subunits in aldosterone-responsive epithelia from the rat: localization by in situ hybridization and immunocytochemistry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8264740" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Brief report: Liddle's syndrome revisited--a disorder of sodium reabsorption in the distal tubule.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9552093" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Liddle's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27896928" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Liddle syndrome: clinical and genetic profiles.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34414500" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Monogenic forms of low-renin hypertension: clinical and molecular insights.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29534496" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Liddle Syndrome: Review of the Literature and Description of a New Case.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9100575" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Liddle's syndrome: prospective genetic screening and suppressed aldosterone secretion in an extended kindred.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12714866" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : A new mutation, R563Q, of the beta subunit of the epithelial sodium channel associated with low-renin, low-aldosterone hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8521520" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Mechanism by which Liddle's syndrome mutations increase activity of a human epithelial Na+ channel.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7550319" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15153548" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Renal epithelial traffic jams and one-way streets.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31564964" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Liddle's syndrome mechanisms, diagnosis and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9792722" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Inhibition of the epithelial Na+ channel by interaction of Nedd4 with a PY motif deleted in Liddle's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10074483" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Defective regulation of the epithelial Na+ channel by Nedd4 in Liddle's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7954808" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7777572" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : A mutation in the epithelial sodium channel causing Liddle disease increases channel activity in the Xenopus laevis oocyte expression system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8524790" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : A de novo missense mutation of the beta subunit of the epithelial sodium channel causes hypertension and Liddle syndrome, identifying a proline-rich segment critical for regulation of channel activity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15483078" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Liddle's syndrome caused by a novel mutation in the proline-rich PY motif of the epithelial sodium channel beta-subunit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18398334" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Liddle's syndrome caused by a novel missense mutation (P617L) of the epithelial sodium channel beta subunit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12759227" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Epithelial Na+ channel mutants causing Liddle's syndrome retain ability to respond to aldosterone and vasopressin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11228173" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Two sporadic cases of Liddle's syndrome caused by De novo ENaC mutations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16580612" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Inherited sodium avid states.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9350583" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Genotype-phenotype analysis of a newly discovered family with Liddle's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6262354" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : The effect of triamterene and sodium intake on renin, aldosterone, and erythrocyte sodium transport in Liddle's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1149690" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Two cases of pseudoaldosteronism (Liddle's syndrome) in siblings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3944906" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Pseudohyperaldosteronism (Liddle's syndrome): a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6273144" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Hypertension, hypokalemia and hypoaldosteronism with suppressed renin: a clinical study of a patient with Liddle's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1939532" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Type I pseudohypoaldosteronism includes two clinically and genetically distinct entities with either renal or multiple target organ defects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2137831" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Pseudohypoaldosteronism in eight families: different forms of inheritance are evidence for various genetic defects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12191985" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Disturbances of Na/K balance: pseudohypoaldosteronism revisited.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21664233" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Aldosterone resistance: structural and functional considerations and new perspectives.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8589714" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36320629" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Acid-Base Imbalance in Pseudohypoaldosteronism Type 1 in Comparison With Type IV Renal Tubular Acidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7965429" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Pseudohypoaldosteronism with increased sweat and saliva electrolyte values and frequent lower respiratory tract infections mimicking cystic fibrosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10403853" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Pulmonary epithelial sodium-channel dysfunction and excess airway liquid in pseudohypoaldosteronism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8589728" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Early death due to defective neonatal lung liquid clearance in alpha-ENaC-deficient mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9990092" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Disruption of the beta subunit of the epithelial Na+ channel in mice: hyperkalemia and neonatal death associated with a pseudohypoaldosteronism phenotype.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7962269" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Physiological and molecular aspects of mineralocorticoid receptor action in pseudohypoaldosteronism: a responsiveness test and therapy.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
